CD19 and neoplasm: CD19 CAR-T cells effectively killed KOPN-49 and REH cells during the first tumor challenge but failed to control tumor growth in the third round, likely due to T cell exhaustion induced by multiple antigen stimulation (Fig. 2c, Supplementary Fig. 3b).